María Torres-Durán
University Hospital Complex Of Vigo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by María Torres-Durán.
European Respiratory Journal | 2014
María Torres-Durán; Alberto Ruano-Ravina; Isaura Parente-Lamelas; Virginia Leiro-Fernández; José Abal-Arca; Carmen Montero-Martínez; Carolina Pena-Álvarez; Francisco Javier González-Barcala; Olalla Castro-Añón; Cristina Martínez; María José Mejuto-Martí; Alberto Fernández-Villar; Juan Miguel Barros-Dios
The aim of the study was to assess the effect of residential radon exposure on the risk of lung cancer in never-smokers and to ascertain if environmental tobacco smoke modifies the effect of residential radon. We designed a multicentre hospital-based case–control study in a radon-prone area (Galicia, Spain). All participants were never-smokers. Cases had an anatomopathologically confirmed primary lung cancer and controls were recruited from individuals undergoing minor, non-oncological surgery. Residential radon was measured using alpha track detectors. We included 521 individuals, 192 cases and 329 controls, 21% were males. We observed an odds ratio of 2.42 (95% CI 1.45–4.06) for individuals exposed to ≥200 Bq·m−3 compared with those exposed to <100 Bq·m−3. Environmental tobacco smoke exposure at home increased lung cancer risk in individuals with radon exposure >200 Bq·m−3. Individuals exposed to environmental tobacco smoke and to radon concentrations >200 Bq·m−3 had higher lung cancer risk than those exposed to lower radon concentrations and exposed to environmental tobacco smoke. Residential radon increases lung cancer risk in never-smokers. An association between residential radon exposure and environmental tobacco smoke on the risk of lung cancer might exist. Residential radon exposure increases risk of lung cancer in never-smokers, ETS exposure may raise radon effect http://ow.ly/xRVte For editorial comments see page 850.
Cancer Letters | 2014
María Torres-Durán; Juan Miguel Barros-Dios; Alberto Fernández-Villar; Alberto Ruano-Ravina
Radon exposure is considered the second cause of lung cancer and the first in never smokers. We aim to assess the effect of residential radon exposure on the risk of lung cancer in never smokers through a systematic review applying predefined inclusion and exclusion criteria. 14 Studies were included. Some of them point to a relationship between residential radon and lung cancer while others show no association. Further studies are necessary to test this association and to assess if other risk factors such as environmental tobacco smoke could modify the effect of residential radon exposure on lung cancer.
European Respiratory Journal | 2016
María Torres-Durán; Alberto Ruano-Ravina; Karl T. Kelsey; Isaura Parente-Lamelas; Mariano Provencio; Leiro-Fernández; José Abal-Arca; Carmen Montero-Martínez; Iria Vidal-García; Carolina Pena; Olalla Castro-Añón; Cristina Esteban Martínez; Roxyris Guzmán-Taveras; María José Mejuto-Martí; Alberto Fernández-Villar; Juan Miguel Barros-Dios
Our aim was to describe the characteristics of a case-series of never-smoker small cell lung cancer (SCLC) cases. Cases of SCLC were selected from a prospective, multicenter, hospital-based case–control study performed in Spain. Participants were never-smokers older than 30 years with an anatomo-pathological confirmation of primary lung cancer. We collected clinical and epidemiological variables according to the studys protocol. We included 19 SCLC cases, 18 females (94.7%), median age 75 years (interquartile range (IQR) 70–80 years). Median residential radon concentration was 195 Bq·m−3 (IQR 130–229 Bq·m−3). 10 patients had limited disease and nine had extended disease. Median survival was 242 days (IQR 94–496 days); 1- and 2-year survival were 36.8% and 17.6%, respectively. Survival was much higher for individuals with limited disease than for those with extended disease (median 336 versus 235 days; 1-year survival 50% versus 22.2% and 2-year survival 27% versus 0%, respectively). Performance status at diagnosis was closely related to survival. SCLC is an infrequent, highly aggressive disease in never-smokers. Survival is poor, even for limited disease. Age at diagnosis in SCLC is higher than that observed for never-smokers with adenocarcinoma. Residential radon exposure is higher than the action levels recommended by the World Health Organization. Small cell lung cancer in never-smokers has a poor survival and is diagnosed at older ages than other lung cancers http://ow.ly/USS2W
European Respiratory Journal | 2016
Alberto Ruano-Ravina; María Torres-Durán; Karl T. Kelsey; Isaura Parente-Lamelas; Virginia Leiro-Fernández; Ihab Abdulkader; José Abal-Arca; Carmen Montero-Martínez; Iria Vidal-García; Margarita Amenedo; Olalla Castro-Añón; Javier González-Barcala; Cristina Martínez; Rosirys Guzmán-Taveras; Mariano Provencio; María José Mejuto-Martí; Alberto Fernández-Villar; Juan Miguel Barros-Dios
The aim of this study was to assess if residential radon exposure might cause EGFR mutations or ALK rearrangements in never-smokers. We designed a multicentre case–control study in a radon-prone area (Galicia, Spain); only lung cancer cases were included in the study. We obtained residential radon measurements and clinical information for all the participants. We compared the median values of residential radon between patients with EGFR mutations or ALK rearrangements versus those without them. 323 patients were included. Median age was 70 years and 19.5% were males. 42 and 15% of patients were EGFR- and ALK-positive, respectively. The most frequent EGFR alterations were exon 19 deletions and exon 21 (L858R) single-point substitution mutations. ALK-positive patients were 10 years younger than ALK-negative patients. Residential radon levels were two-fold higher in patients with exon 19 deletions compared with patients with exon 21 (L858R) single-point substitution mutations (216 versus 118 Bq·m−3; p=0.057). There were no differences in residential radon levels by EGFR mutation status. ALK-positive patients (n=12) essentially had two-fold residential radon levels compared with ALK-negative patients (290 versus 164 Bq·m−3, respectively). Residential radon may have a role in the molecular signature of lung cancer in never-smokers, although more studies with larger sample sizes are needed to support this hypothesis. Residential radon might cause genetic alterations in driver genes for lung cancer in never-smokers http://ow.ly/1u4P302JdBs
International Journal of Radiation Biology | 2015
María Torres-Durán; Alberto Ruano-Ravina; Isaura Parente-Lamelas; Virginia Leiro-Fernández; José Abal-Arca; Carmen Montero-Martínez; Carolina Pena-Álvarez; Olalla Castro-Añón; Cristina Martínez; Rosirys Guzmán-Taveras; María José Mejuto-Martí; Mariano Provencio; Alberto Fernández-Villar; Juan Miguel Barros-Dios
Abstract Purpose: The aim of this study is to assess if there is a relationship between residential radon and lung cancer histological types and patients’ age at diagnosis. Materials and methods: We conducted a multicenter hospital-based case-control study with eight participating hospitals. We included 216 never-smoking cases with primary lung cancer and 329 never-smoking controls. Controls were frequency matched with cases on age and sex distribution. Of them, 198 cases (91.7%) and 275 controls (83.5%) had residential radon measurements. Results: Lung cancer risk reached statistical significance only for adenocarcinoma (Odds ratio [OR] 2.19; 95% Confidence interval [CI] 1.44–3.33), for other histologies the results were marginally significant. Residential radon level was higher for patients diagnosed before 50 and 60 years old than for older lung cancer cases. Conclusions: Residential radon in never smokers seems to be a risk factor for all lung cancer histologies. Individuals diagnosed at a younger age have a higher residential radon concentration, suggesting an accumulative effect on lung cancer appearance.
Environmental Research | 2014
Alberto Ruano-Ravina; José Antonio García-Lavandeira; María Torres-Durán; Luciana Prini-Guadalupe; Isaura Parente-Lamelas; Virginia Leiro-Fernández; Carmen Montero-Martínez; Francisco Javier González-Barcala; Cristina Martínez; Olalla Castro-Añón; María José Mejuto-Martí; Juan Miguel Barros-Dios
We aim to assess the relationship between leisure time activities related to exposure to carcinogenic substances and lung cancer risk in a hospital-based case-control study performed in never smokers. We included never smoking cases with anatomopathologically confirmed lung cancer and never smoking controls undergoing trivial surgery, at 8 Spanish hospitals. The study was conducted between January 2011 and June 2013. Participants were older than 30 and had no previous neoplasms. All were personally interviewed focusing on lifestyle, environmental tobacco smoke exposure, occupational history and leisure time activities (including duration of such activities). Results were analyzed through logistic regression and adjusted also by residential radon and education level. We included 513 never smokers, 191 cases and 322 controls. The OR for those performing the studied leisure time activities was 1.43 (95%CI 0.78-2.61). When we restricted the analysis to those performing do-it-yourself activities for more than 10 years the OR was 2.21 (95%CI 0.93-5.27). Environmental tobacco smoke exposure did not modify this association. The effect for the different lung cancer histological types was very close to significance for adenocarcinoma but only when these activities were performed for more than 10 years. We encourage health professionals to recommend protective measures for those individuals while performing these hobbies to reduce the risk of lung cancer.
Journal of Thoracic Oncology | 2016
María Torres-Durán; Alberto Fernández-Villar; Juan Miguel Barros-Dios; Alberto Ruano-Ravina
There are some published scores to estimate lung cancer risk of mortality or incidence. Nevertheless, no score has included residential radon as a variable to be considered when estimating lung cancer risk. In this commentary we discuss the importance of including residential radon as a factor to be taken into account when calculating lung cancer risk.
Journal of Thoracic Oncology | 2015
María Torres-Durán; Alberto Ruano-Ravina; Isaura Parente-Lamelas; José Abal-Arca; Virginia Leiro-Fernández; Carmen Montero-Martínez; Carolina Pena; Olalla Castro-Añón; Francisco Javier González-Barcala; Cristina Martínez; Rosirys Guzmán-Taveras; Mariano Provencio; María José Mejuto-Martí; Alberto Fernández-Villar; Juan Miguel Barros-Dios
Background: Never-smokers comprise up to 25% of all lung cancer cases. They could have different molecular pathways for lung cancer induction compared with smokers. Alpha-1 antitrypsin (AAT) deficiency is a hereditary trait whose main characteristic is early onset of lung emphysema. Our aim is to know if AAT-deficient carriers have a higher risk of lung cancer in a study performed exclusively in never-smokers. Methods: We designed a multicentre hospital-based case–control study, which included incident never-smoking lung cancer cases. Controls were never-smokers attending nonmajor surgery at the participating hospitals. Controls were frequency matched on age and gender with cases. We determined AAT variants (alleles S and Z) through polymerase chain reaction. Results: Two hundred and twelve cases and 318 controls were included. PiSS individuals showed a lung cancer risk of 4.64 (95% confidence interval: 1.08–19.92) compared with those with normal genotype (PiMM). When the analysis was restricted to women, the risk for PiSS increased to 7.58 (95% confidence interval: 1.40–40.87). This risk for homozygous SS was even higher for individuals exposed to environmental tobacco smoke (greater than 20 years). The presence of other alleles did not show any effect on lung cancer risk. Conclusions: Never smoking SS homozygous individuals pose an increased risk of lung cancer. The risk is higher for individuals exposed to environmental tobacco smoke.
European Journal of Public Health | 2018
José A García Lavandeira; Alberto Ruano-Ravina; Karl T. Kelsey; María Torres-Durán; Isaura Parente-Lamelas; Virginia Leiro-Fernández; Maruxa Zapata; José Abal-Arca; Iria Vidal-García; Carmen Montero-Martínez; Margarita Amenedo; Olalla Castro-Añón; Rosirys Guzmán-Taveras; Cristina Martínez; Mariano Provencio; María José Mejuto-Martí; Silvia García-García; Alberto Fernández-Villar; María Piñeiro; Juan Miguel Barros-Dios
Background Lung cancer is the deadliest cancer in developed countries but the etiology of lung cancer risk in never smokers (LCRINS) is largely unknown. We aim to assess the effects of alcohol consumption, in its different forms, on LCRINS. Methods We pooled six multi-center case-control studies developed in the northwest of Spain. Cases and controls groups were composed of never smokers. We selected incident cases with anatomopathologically confirmed lung cancer diagnoses. All participants were personally interviewed. We performed two groups of statistical models, applying unconditional logistic regression with generalized additive models. One considered the effect of alcohol type consumption and the other considered the quantity of each alcoholic beverage consumed. Results A total of 438 cases and 863 controls were included. Median age was 71 and 66, years, respectively. Adenocarcinoma was the predominant histological type, comprising 66% of all cases. We found that any type of wine consumption posed an OR of 2.20 OR 95%CI 1.12-4.35), and spirits consumption had an OR of 1.90 (95%CI 1.13-3.23). Beer consumption had an OR of 1.33 (95%CI 0.82-2.14). These results were similar when women were analyzed separately, but for men there was no apparent risk for any alcoholic beverage. The dose-response analysis for each alcoholic beverage revealed no clear pattern. Conclusions Wine and spirits consumption might increase the risk of LCRINSs, particularly in females. These results have to be taken with caution given the limitations of the present study.
Archivos De Bronconeumologia | 2017
Ángeles Rodríguez-Martínez; Alberto Ruano-Ravina; María Torres-Durán; Iria Vidal-García; Virginia Leiro-Fernández; Jesús R. Hernández-Hernández; Silvia García-García; Mariano Provencio; Olalla Castro-Añón; Isaura Parente-Lamelas; Ihab Abdulkader; José Abal-Arca; Carmen Montero-Martínez; Margarita Amenedo; Rosirys Guzmán-Taveras; Alberto Fernández-Villar; Juan Miguel Barros-Dios
espanolIntroduccion El cancer de pulmon de celula pequena (CPCP) es el tipo histologico mas agresivo de las neoplasias broncopulmonares. Representa en torno al 10-15% de todos los casos. Muy pocos estudios han analizado la influencia del radon residencial. Se pretende conocer los factores de riesgo del CPCP. Metodos Se diseno un estudio de casos y controles multicentrico y de base hospitalaria, con 11 hospitales de 4 comunidades autonomas. Resultados Se analizan los primeros 113 casos reclutados y de ellos 63 con resultados de radon residencial. La edad mediana al diagnostico fue de 63 anos y un 11% de los casos eran menores de 50 anos. El 22% de los casos eran mujeres. El 57% tenian enfermedad en estadio IV y el 95% eran fumadores o exfumadores. La concentracion mediana de radon residencial era de 128 Bq/m3. Un 8% de los casos tenian concentraciones superiores a 400 Bq/m3. Por sexo, la unica diferencia relevante fue en el porcentaje de mujeres nunca fumadoras, mas elevado que para los hombres (p Conclusiones Existe un diagnostico a una edad temprana en buena parte de los casos con CPCP y predomina la enfermedad metastasica al diagnostico. El radon residencial parece jugar un papel importante en la aparicion de la enfermedad, existiendo casos diagnosticados con concentraciones de radon muy elevadas EnglishIntroduction Small cell lung cancer (SCLC) is the most aggressive histologic type of lung cancer, and accounts for approximately 10%-15% of all cases. Few studies have analyzed the effect of residential radon. Our aim is to determine the risk factors of SCLC. Methods We designed a multicenter, hospital-based case-control study with the participation of 11 hospitals in 4 autonomous communities. Results Results of the first 113 cases have been analyzed, 63 of which included residential radon measurements. Median age at diagnosis was 63 years; 11% of cases were younger than 50 years of age; 22% were women; 57% had extended disease; and 95% were smokers or former smokers. Median residential radon concentration was 128 Bq/m3. Concentrations higher than 400 Bq/m3 were found in 8% of cases. The only remarkable difference by gender was the percentage of never smokers, which was higher in women compared to men (P Conclusions A high percentage of SCLC cases are diagnosed early and there is a predominance of disseminated disease at diagnosis. Residential radon seems to play an important role on the onset of this disease, with some cases having very high indoor radon concentrations.INTRODUCTION Small cell lung cancer (SCLC) is the most aggressive histologic type of lung cancer, and accounts for approximately 10%-15% of all cases. Few studies have analyzed the effect of residential radon. Our aim is to determine the risk factors of SCLC. METHODS We designed a multicenter, hospital-based case-control study with the participation of 11 hospitals in 4 autonomous communities. RESULTS Results of the first 113 cases have been analyzed, 63 of which included residential radon measurements. Median age at diagnosis was 63 years; 11% of cases were younger than 50 years of age; 22% were women; 57% had extended disease; and 95% were smokers or former smokers. Median residential radon concentration was 128Bq/m3. Concentrations higher than 400Bq/m3 were found in 8% of cases. The only remarkable difference by gender was the percentage of never smokers, which was higher in women compared to men (P<.001). Radon concentration was higher in patients with stageIV disease (non-significant difference) and in individuals diagnosed at 63 years of age or older (P=.032). CONCLUSIONS A high percentage of SCLC cases are diagnosed early and there is a predominance of disseminated disease at diagnosis. Residential radon seems to play an important role on the onset of this disease, with some cases having very high indoor radon concentrations.